NCT05406115View on ClinicalTrials.gov

Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity

PHASE1CompletedINTERVENTIONAL

Enrollment

65

Participants

Timeline

Start Date

July 26, 2022

Primary Completion Date

August 21, 2023

Study Completion Date

August 21, 2023

Conditions

Obesity

Interventions

DRUG

AMG 786

Oral tablet

OTHER

Placebo

Oral tablet

Trial Locations (3)

33014

Clinical Pharmacology of Miami, LLC, Miami

33180

Translational Clinical Research LLC, Aventura

92780

Orange County Research Center, Tustin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY